Report Cover

Global Biologic Therapeutics Drugs Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    Humans
    Avian Cell Culture
    Yeast
    Bacteria
    Insects Cell Culture
    Transgenics

Segment by Application
    Rheumatoid Arthritis
    Anemia
    Cancer
    Diabetes
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E

By Company
    Pfizer
    AstraZeneca
    Novartis
    Merck
    Smith Medical
    GlaxoSmithKline
    Concord Biotech
    Aurobindo Pharma
    H. Lundbeck
    Retractable Technologies
1 Biologic Therapeutics Drugs Market Overview
    1.1 Product Overview and Scope of Biologic Therapeutics Drugs
    1.2 Biologic Therapeutics Drugs Segment by Type
        1.2.1 Global Biologic Therapeutics Drugs Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Humans
        1.2.3 Avian Cell Culture
        1.2.4 Yeast
        1.2.5 Bacteria
        1.2.6 Insects Cell Culture
        1.2.7 Transgenics
    1.3 Biologic Therapeutics Drugs Segment by Application
        1.3.1 Biologic Therapeutics Drugs Sales Comparison by Application: (2021-2027)
        1.3.2 Rheumatoid Arthritis
        1.3.3 Anemia
        1.3.4 Cancer
        1.3.5 Diabetes
        1.3.6 Others
    1.4 Global Biologic Therapeutics Drugs Market Size Estimates and Forecasts
        1.4.1 Global Biologic Therapeutics Drugs Revenue 2016-2027
        1.4.2 Global Biologic Therapeutics Drugs Sales 2016-2027
        1.4.3 Biologic Therapeutics Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Biologic Therapeutics Drugs Market Competition by Manufacturers
    2.1 Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Biologic Therapeutics Drugs Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Biologic Therapeutics Drugs Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Biologic Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Biologic Therapeutics Drugs Market Competitive Situation and Trends
        2.5.1 Biologic Therapeutics Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Biologic Therapeutics Drugs Players Market Share by Revenue
        2.5.3 Global Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Biologic Therapeutics Drugs Retrospective Market Scenario by Region
    3.1 Global Biologic Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Biologic Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Biologic Therapeutics Drugs Market Facts & Figures by Country
        3.3.1 North America Biologic Therapeutics Drugs Sales by Country
        3.3.2 North America Biologic Therapeutics Drugs Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Biologic Therapeutics Drugs Market Facts & Figures by Country
        3.4.1 Europe Biologic Therapeutics Drugs Sales by Country
        3.4.2 Europe Biologic Therapeutics Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Biologic Therapeutics Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Biologic Therapeutics Drugs Sales by Region
        3.5.2 Asia Pacific Biologic Therapeutics Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Biologic Therapeutics Drugs Market Facts & Figures by Country
        3.6.1 Latin America Biologic Therapeutics Drugs Sales by Country
        3.6.2 Latin America Biologic Therapeutics Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Biologic Therapeutics Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Country
        3.7.2 Middle East and Africa Biologic Therapeutics Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Biologic Therapeutics Drugs Historic Market Analysis by Type
    4.1 Global Biologic Therapeutics Drugs Sales Market Share by Type (2016-2021)
    4.2 Global Biologic Therapeutics Drugs Revenue Market Share by Type (2016-2021)
    4.3 Global Biologic Therapeutics Drugs Price by Type (2016-2021)

5 Global Biologic Therapeutics Drugs Historic Market Analysis by Application
    5.1 Global Biologic Therapeutics Drugs Sales Market Share by Application (2016-2021)
    5.2 Global Biologic Therapeutics Drugs Revenue Market Share by Application (2016-2021)
    5.3 Global Biologic Therapeutics Drugs Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Pfizer
        6.1.1 Pfizer Corporation Information
        6.1.2 Pfizer Description and Business Overview
        6.1.3 Pfizer Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Pfizer Product Portfolio
        6.1.5 Pfizer Recent Developments/Updates
    6.2 AstraZeneca
        6.2.1 AstraZeneca Corporation Information
        6.2.2 AstraZeneca Description and Business Overview
        6.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 AstraZeneca Product Portfolio
        6.2.5 AstraZeneca Recent Developments/Updates
    6.3 Novartis
        6.3.1 Novartis Corporation Information
        6.3.2 Novartis Description and Business Overview
        6.3.3 Novartis Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Novartis Product Portfolio
        6.3.5 Novartis Recent Developments/Updates
    6.4 Merck
        6.4.1 Merck Corporation Information
        6.4.2 Merck Description and Business Overview
        6.4.3 Merck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Merck Product Portfolio
        6.4.5 Merck Recent Developments/Updates
    6.5 Smith Medical
        6.5.1 Smith Medical Corporation Information
        6.5.2 Smith Medical Description and Business Overview
        6.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Smith Medical Product Portfolio
        6.5.5 Smith Medical Recent Developments/Updates
    6.6 GlaxoSmithKline
        6.6.1 GlaxoSmithKline Corporation Information
        6.6.2 GlaxoSmithKline Description and Business Overview
        6.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 GlaxoSmithKline Product Portfolio
        6.6.5 GlaxoSmithKline Recent Developments/Updates
    6.7 Concord Biotech
        6.6.1 Concord Biotech Corporation Information
        6.6.2 Concord Biotech Description and Business Overview
        6.6.3 Concord Biotech Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Concord Biotech Product Portfolio
        6.7.5 Concord Biotech Recent Developments/Updates
    6.8 Aurobindo Pharma
        6.8.1 Aurobindo Pharma Corporation Information
        6.8.2 Aurobindo Pharma Description and Business Overview
        6.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Aurobindo Pharma Product Portfolio
        6.8.5 Aurobindo Pharma Recent Developments/Updates
    6.9 H. Lundbeck
        6.9.1 H. Lundbeck Corporation Information
        6.9.2 H. Lundbeck Description and Business Overview
        6.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 H. Lundbeck Product Portfolio
        6.9.5 H. Lundbeck Recent Developments/Updates
    6.10 Retractable Technologies
        6.10.1 Retractable Technologies Corporation Information
        6.10.2 Retractable Technologies Description and Business Overview
        6.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Retractable Technologies Product Portfolio
        6.10.5 Retractable Technologies Recent Developments/Updates

7 Biologic Therapeutics Drugs Manufacturing Cost Analysis
    7.1 Biologic Therapeutics Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Biologic Therapeutics Drugs
    7.4 Biologic Therapeutics Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Biologic Therapeutics Drugs Distributors List
    8.3 Biologic Therapeutics Drugs Customers

9 Biologic Therapeutics Drugs Market Dynamics
    9.1 Biologic Therapeutics Drugs Industry Trends
    9.2 Biologic Therapeutics Drugs Growth Drivers
    9.3 Biologic Therapeutics Drugs Market Challenges
    9.4 Biologic Therapeutics Drugs Market Restraints

10 Global Market Forecast
    10.1 Biologic Therapeutics Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Biologic Therapeutics Drugs by Type (2022-2027)
    10.2 Biologic Therapeutics Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Biologic Therapeutics Drugs by Application (2022-2027)
    10.3 Biologic Therapeutics Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Biologic Therapeutics Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Biologic Therapeutics Drugs Sales (MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Biologic Therapeutics Drugs Sales (MT) Comparison by Application (2021-2027) Table 3. Global Biologic Therapeutics Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Biologic Therapeutics Drugs Covered in This Study Table 5. Global Biologic Therapeutics Drugs Sales (MT) of Key Manufacturers (2016-2021) Table 6. Global Biologic Therapeutics Drugs Sales Share by Manufacturers (2016-2021) Table 7. Global Biologic Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Biologic Therapeutics Drugs Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Biologic Therapeutics Drugs Average Price (USD/Kg) of Key Manufacturers (2016-2021) Table 10. Manufacturers Biologic Therapeutics Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Biologic Therapeutics Drugs Product Type Table 12. Global Biologic Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Biologic Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Therapeutics Drugs as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Biologic Therapeutics Drugs Sales by Region (2016-2021) & (MT) Table 16. Global Biologic Therapeutics Drugs Sales Market Share by Region (2016-2021) Table 17. Global Biologic Therapeutics Drugs Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Biologic Therapeutics Drugs Sales by Country (2016-2021) & (MT) Table 19. North America Biologic Therapeutics Drugs Sales Market Share by Country (2016-2021) Table 20. North America Biologic Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Biologic Therapeutics Drugs Revenue Market Share by Country (2016-2021) Table 22. Europe Biologic Therapeutics Drugs Sales by Country (2016-2021) & (MT) Table 23. Europe Biologic Therapeutics Drugs Sales Market Share by Country (2016-2021) Table 24. Europe Biologic Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Biologic Therapeutics Drugs Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Biologic Therapeutics Drugs Sales by Region (2016-2021) & (MT) Table 27. Asia Pacific Biologic Therapeutics Drugs Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Biologic Therapeutics Drugs Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Biologic Therapeutics Drugs Revenue Market Share by Region (2016-2021) Table 30. Latin America Biologic Therapeutics Drugs Sales by Country (2016-2021) & (MT) Table 31. Latin America Biologic Therapeutics Drugs Sales Market Share by Country (2016-2021) Table 32. Latin America Biologic Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Biologic Therapeutics Drugs Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2016-2021) & (MT) Table 35. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Biologic Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Biologic Therapeutics Drugs Revenue Market Share by Country (2016-2021) Table 38. Global Biologic Therapeutics Drugs Sales (MT) by Type (2016-2021) Table 39. Global Biologic Therapeutics Drugs Sales Market Share by Type (2016-2021) Table 40. Global Biologic Therapeutics Drugs Revenue (Million US$) by Type (2016-2021) Table 41. Global Biologic Therapeutics Drugs Revenue Share by Type (2016-2021) Table 42. Global Biologic Therapeutics Drugs Price (USD/Kg) by Type (2016-2021) Table 43. Global Biologic Therapeutics Drugs Sales (MT) by Application (2016-2021) Table 44. Global Biologic Therapeutics Drugs Sales Market Share by Application (2016-2021) Table 45. Global Biologic Therapeutics Drugs Revenue (Million US$) by Application (2016-2021) Table 46. Global Biologic Therapeutics Drugs Revenue Share by Application (2016-2021) Table 47. Global Biologic Therapeutics Drugs Price (USD/Kg) by Application (2016-2021) Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Biologic Therapeutics Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 51. Pfizer Biologic Therapeutics Drugs Product Table 52. Pfizer Recent Developments/Updates Table 53. AstraZeneca Corporation Information Table 54. AstraZeneca Description and Business Overview Table 55. AstraZeneca Biologic Therapeutics Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 56. AstraZeneca Biologic Therapeutics Drugs Product Table 57. AstraZeneca Recent Developments/Updates Table 58. Novartis Corporation Information Table 59. Novartis Description and Business Overview Table 60. Novartis Biologic Therapeutics Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 61. Novartis Biologic Therapeutics Drugs Product Table 62. Novartis Recent Developments/Updates Table 63. Merck Corporation Information Table 64. Merck Description and Business Overview Table 65. Merck Biologic Therapeutics Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 66. Merck Biologic Therapeutics Drugs Product Table 67. Merck Recent Developments/Updates Table 68. Smith Medical Corporation Information Table 69. Smith Medical Description and Business Overview Table 70. Smith Medical Biologic Therapeutics Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 71. Smith Medical Biologic Therapeutics Drugs Product Table 72. Smith Medical Recent Developments/Updates Table 73. GlaxoSmithKline Corporation Information Table 74. GlaxoSmithKline Description and Business Overview Table 75. GlaxoSmithKline Biologic Therapeutics Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 76. GlaxoSmithKline Biologic Therapeutics Drugs Product Table 77. GlaxoSmithKline Recent Developments/Updates Table 78. Concord Biotech Corporation Information Table 79. Concord Biotech Description and Business Overview Table 80. Concord Biotech Biologic Therapeutics Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 81. Concord Biotech Biologic Therapeutics Drugs Product Table 82. Concord Biotech Recent Developments/Updates Table 83. Aurobindo Pharma Corporation Information Table 84. Aurobindo Pharma Description and Business Overview Table 85. Aurobindo Pharma Biologic Therapeutics Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 86. Aurobindo Pharma Biologic Therapeutics Drugs Product Table 87. Aurobindo Pharma Recent Developments/Updates Table 88. H. Lundbeck Corporation Information Table 89. H. Lundbeck Description and Business Overview Table 90. H. Lundbeck Biologic Therapeutics Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 91. H. Lundbeck Biologic Therapeutics Drugs Product Table 92. H. Lundbeck Recent Developments/Updates Table 93. Retractable Technologies Corporation Information Table 94. Retractable Technologies Description and Business Overview Table 95. Retractable Technologies Biologic Therapeutics Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 96. Retractable Technologies Biologic Therapeutics Drugs Product Table 97. Retractable Technologies Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Biologic Therapeutics Drugs Distributors List Table 101. Biologic Therapeutics Drugs Customers List Table 102. Biologic Therapeutics Drugs Market Trends Table 103. Biologic Therapeutics Drugs Growth Drivers Table 104. Biologic Therapeutics Drugs Market Restraints Table 105. Global Biologic Therapeutics Drugs Sales Forecast by Type (2022-2027) & (MT) Table 106. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Type (2022-2027) Table 107. Global Biologic Therapeutics Drugs Revenue Forecast by Type (2022-2027) & (US$ Million) Table 108. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Type (2022-2027) Table 109. Global Biologic Therapeutics Drugs Sales Forecast by Application (2022-2027) & (MT) Table 110. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Application (2022-2027) Table 111. Global Biologic Therapeutics Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 112. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Application (2022-2027) Table 113. Global Biologic Therapeutics Drugs Sales Forecast by Region (2022-2027) & (MT) Table 114. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Region (2022-2027) Table 115. Global Biologic Therapeutics Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 116. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Region (2022-2027) Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Biologic Therapeutics Drugs Figure 2. Global Biologic Therapeutics Drugs Market Share by Type in 2020 & 2027 Figure 3. Humans Product Picture Figure 4. Avian Cell Culture Product Picture Figure 5. Yeast Product Picture Figure 6. Bacteria Product Picture Figure 7. Insects Cell Culture Product Picture Figure 8. Transgenics Product Picture Figure 9. Global Biologic Therapeutics Drugs Market Share by Application in 2020 & 2027 Figure 10. Rheumatoid Arthritis Figure 11. Anemia Figure 12. Cancer Figure 13. Diabetes Figure 14. Others Figure 15. Global Biologic Therapeutics Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Biologic Therapeutics Drugs Market Size 2016-2027 (US$ Million) Figure 17. Global Biologic Therapeutics Drugs Sales 2016-2027 (MT) Figure 18. Global Biologic Therapeutics Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 19. Biologic Therapeutics Drugs Sales Share by Manufacturers in 2020 Figure 20. Global Biologic Therapeutics Drugs Revenue Share by Manufacturers in 2020 Figure 21. The Global 5 and 10 Largest Biologic Therapeutics Drugs Players: Market Share by Revenue in 2020 Figure 22. Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 23. Global Biologic Therapeutics Drugs Sales Market Share by Region (2016-2021) Figure 24. Global Biologic Therapeutics Drugs Sales Market Share by Region in 2020 Figure 25. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2016-2021) Figure 26. Global Biologic Therapeutics Drugs Revenue Market Share by Region in 2020 Figure 27. U.S. Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Canada Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Germany Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. France Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. U.K. Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Italy Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Russia Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. China Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Japan Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. South Korea Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. India Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Australia Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Taiwan Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Indonesia Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Thailand Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Malaysia Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Philippines Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Vietnam Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Mexico Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Brazil Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Argentina Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Turkey Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Saudi Arabia Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. U.A.E Biologic Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. Sales Market Share of Biologic Therapeutics Drugs by Type (2016-2021) Figure 52. Sales Market Share of Biologic Therapeutics Drugs by Application (2016-2021) Figure 53. Sales Market Share of Biologic Therapeutics Drugs by Application in 2020 Figure 54. Revenue Share of Biologic Therapeutics Drugs by Application (2016-2021) Figure 55. Revenue Share of Biologic Therapeutics Drugs by Application in 2020 Figure 56. Manufacturing Cost Structure of Biologic Therapeutics Drugs Figure 57. Manufacturing Process Analysis of Biologic Therapeutics Drugs Figure 58. Biologic Therapeutics Drugs Industrial Chain Analysis Figure 59. Channels of Distribution Figure 60. Distributors Profiles Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us